1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CORCEPT THERAPEUTICS INC
Corcept Therapeutics Inc XNAS: CORT
Slowing Down Stock
Download real time
41.30 4.99 (13.74%)
64.80% Fall from 52W High
5.9M
XNAS Volume

XNAS 22 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Positive Trial
Corcept rises on Thursday after late-stage trial shows its drug cuts death risk from ovarian cancer See details

Corcept Therapeutics Inc - CORT - stock price prediction, stock price target, analyst ratings from 6 analysts

Corcept Therapeutics Inc has a share price target of US$ 91, revenue growth forecast of 19.3%, and profit growth estimate of -30.6% for FY25, based on top 6 analyst calls.

Forecaster Screeners